LAWRENCE, Mass., Aug. 2, 2016 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading medical technology company
focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, and
Matthew Towse, Chief Financial
Officer, will present at the Canaccord Genuity 36th
Annual Growth Conference on Wednesday,
August 10th at 8:30 a.m.
ET in Boston, MA.
A webcast of the presentation will be made available through the
Investor Relations section of the Company's website at
http://ir.nxstage.com/.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is
a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. NxStage
has also established a small number of dialysis clinics committed
to the development of innovative care delivery models for patients
with ESRD. For more information on NxStage and its products and
services, please visit the Company's website at
http://www.nxstage.com and www.nxstagekidneycare.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Examples of these
forward-looking statements include statements as to Messrs. Burbank
and Towse's plans to present at these conferences. NxStage
specifically disclaims any obligation to update these
forward-looking statements. These forward-looking statements should
not be relied upon as representing NxStage's expectations or
beliefs as of any date subsequent to the date of this press
release.
Contact:
Kristen K. Sheppard,
Esq.
Investor Relations
ksheppard@nxstage.com
Logo
- http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-present-at-canaccord-genuity-36th-annual-growth-conference-300307260.html
SOURCE NxStage Medical, Inc.